Invention Grant
- Patent Title: Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof
-
Application No.: US13959739Application Date: 2013-08-06
-
Publication No.: US09725767B2Publication Date: 2017-08-08
- Inventor: Brunangelo Falini , Cristina Mecucci
- Applicant: Brunangelo Falini , Cristina Mecucci
- Applicant Address: US CA San Diego
- Assignee: Trovagene, Inc.
- Current Assignee: Trovagene, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Lewis Roca Rothgerber Christie LLP
- Agent Holly P. Logue; Elie H. Gendloff
- Priority: ITRM2004A0534 20041029
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07K14/47 ; G01N33/574
Abstract:
The invention relates to new nucleophosmin protein (NPM) mutants, corresponding gene sequences and relative uses thereof for diagnosis, monitoring of minimal residual disease; prognostic evaluation and therapy of the acute myeloid leukaemia (AML).
Public/Granted literature
- US20150184245A1 NUCLEOPHOSMIN PROTEIN (NPM) MUTANTS, CORRESPONDING GENE SEQUENCES AND USES THEREOF Public/Granted day:2015-07-02
Information query
